David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 138,981 shares at $45.27 ($6.5M) on 2021-02-22, disclosed to the SEC on 2021-02-23.
Open-market sale of $6.5M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.02 | 5,200 | $239K | 3.7% |
| 2 | $46.02 | 5,200 | $239K | 3.7% |
| 3 | $47.08 | 21,360 | $1.0M | 15.6% |
| 4 | $47.08 | 21,360 | $1.0M | 15.6% |
| 5 | $47.61 | 18,316 | $872K | 13.5% |
| 6 | $47.61 | 18,316 |
| $872K |
| 13.5% |
| 7 | $45.27 | 11,482 | $520K | 8.0% |
| 8 | $45.27 | 11,482 | $520K | 8.0% |
| 9 | $46.03 | 7,241 | $333K | 5.2% |
| 10 | $46.03 | 7,241 | $333K | 5.2% |
| 11 | $46.99 | 1,417 | $67K | 1.0% |
| 12 | $46.99 | 1,417 | $67K | 1.0% |
| 13 | $42.50 | 1,019 | $43K | 0.7% |
| 14 | $43.35 | 1,881 | $82K | 1.3% |
| 15 | $43.35 | 1,881 | $82K | 1.3% |
| 16 | $44.70 | 2,084 | $93K | 1.4% |
| 17 | $44.70 | 2,084 | $93K | 1.4% |
| Total | $46.52 avg | 138,981 | $6.5M | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |